利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

76 条记录 (耗时 0.042 秒)

    Substituted 5,6,7,8-tetrahydropyrido[4,3-D]pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
    16.
    发明授权
    Substituted 5,6,7,8-tetrahydropyrido[4,3-D]pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes 有权
    取代5,6,7,8-四氢吡啶并[4,3-D]嘧啶作为二肽基肽酶-IV抑制剂，用于治疗或预防糖尿病

    公开(公告)号：US07928112B2

    公开(公告)日：2011-04-19

    申请号：US12869869

    申请日：2010-08-27

    申请人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    发明人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    IPC分类号： A61K31/519

    CPC分类号： C07D487/04 ,  C07D471/04

    摘要： The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

    摘要翻译： 本发明涉及结构式I的新型取代的氨基四氢吡喃，其是二肽基肽酶-IV酶的抑制剂，其可用于治疗或预防涉及二肽基肽酶-IV酶的疾病，例如糖尿病，特别是 2型糖尿病 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及二肽基肽酶-IV酶的疾病中的用途。

    Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
    18.
    发明授权
    Substitued [1,2,4]triazolo[1,5-a]pyrazines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes 有权
    取代的[1,2,4]三唑并[1,5-a]吡嗪作为二肽基肽酶-IV抑制剂用于治疗或预防糖尿病

    公开(公告)号：US07812027B2

    公开(公告)日：2010-10-12

    申请号：US12226584

    申请日：2007-05-11

    申请人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    发明人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    IPC分类号： A61K31/50

    CPC分类号： C07D487/04 ,  C07D471/04

    摘要： The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

    摘要翻译： 本发明涉及结构式I的新型取代的氨基四氢吡喃，其是二肽基肽酶-IV酶的抑制剂，其可用于治疗或预防涉及二肽基肽酶-IV酶的疾病，例如糖尿病，特别是 2型糖尿病 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及二肽基肽酶-IV酶的疾病中的用途。

    Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
    19.
    发明申请
    Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes 有权
    氨基四氢吡喃作为二肽基肽酶-IV抑制剂用于治疗或预防糖尿病

    公开(公告)号：US20090209544A1

    公开(公告)日：2009-08-20

    申请号：US12226584

    申请日：2007-05-11

    申请人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    发明人： Tesfaye Biftu ,  Ping Chen ,  Danqing Feng ,  Ann E. Weber

    IPC分类号： A61K31/4985 ,  A61K31/519 ,  A61K31/437 ,  C07D471/04 ,  C07D487/04 ,  C07D498/04 ,  A61P3/10

    CPC分类号： C07D487/04 ,  C07D471/04

    摘要： The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

    摘要翻译： 本发明涉及结构式I的新型取代的氨基四氢吡喃，其是二肽基肽酶-IV酶的抑制剂，其可用于治疗或预防涉及二肽基肽酶-IV酶的疾病，例如糖尿病，特别是 2型糖尿病 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及二肽基肽酶-IV酶的疾病中的用途。